Foghorn Therapeutics Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Cambridge, MA
FHTX chart
What traders are saying about $FHTX
Latest postsFoghorn Therapeutics Inc. news
- Lawsuit probes Foghorn Therapeutics after trial halt and 40% staff cut cause 31% stock drop
Pluang ·
- Could You Have Seen The Run In Kymera Stock Coming?
trefis.com ·
- Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga
The National Law Review ·
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Foghorn Therapeutics Inc. - FHTX
PR Newswire ·
- Foghorn Therapeutics (FHTX) Stock Fair Value Moves Lower After Pipeline And Lilly Reset
Yahoo Finance ·
- Foghorn Therapeutics Inc (FHTX-Q) Stock Price and News
The Globe and Mail ·
- FHTX Stock Extends Sell-Off After Lilly Collaboration Ends — Wedbush Slashes Target By 80%
stocktwits.com ·
- Foghorn Therapeutics layoffs after Eli Lilly ends cancer deal
qz.com ·
- Correction: Top Midday Decliners
Yahoo Finance ·
- Sector Update: Healthcare Stocks Fall Late Afternoon
Yahoo Finance ·
- Foghorn Stock Sinks as Lilly Scraps Cancer Deal, Forcing 40% Layoffs
Yahoo Finance ·
- Top Midday Decliners
Yahoo Finance ·
Foghorn Therapeutics Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $30.9M | $22.6M | $34.2M | $19.2M |
| Net income | -$74.3M | -$86.6M | -$98.4M | -$108.9M |
| Diluted EPS | $-1.18 | $-1.58 | $-2.34 | $-2.62 |
| Total assets (year end) | $198.1M | $284.0M | $285.9M | $404.9M |
| Cash and equivalents (year end) | $80.9M | $55.5M | $80.3M | $52.2M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Foghorn Therapeutics Inc.
- Ticker
- FHTX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Cambridge, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1822462
Frequently asked questions
What exchange is Foghorn Therapeutics Inc. listed on?
Foghorn Therapeutics Inc. trades on the Nasdaq under the ticker symbol FHTX.
What industry is Foghorn Therapeutics Inc. in?
Foghorn Therapeutics Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Foghorn Therapeutics Inc. headquartered?
Foghorn Therapeutics Inc.'s business address on file with the SEC is in Cambridge, MA.
When does Foghorn Therapeutics Inc.'s fiscal year end?
Foghorn Therapeutics Inc.'s fiscal year ends on December 31.
How much revenue did Foghorn Therapeutics Inc. report?
Foghorn Therapeutics Inc. reported $30.9M in revenue for calendar year 2025, according to its SEC filings.